147.59 USD
+5.11 (+3.59%)
147.59 USD
0 (0%)
Taking everything into account, ICUI scores 4 out of 10 in our fundamental rating. ICUI was compared to 187 industry peers in the Health Care Equipment & Supplies industry. ICUI has only an average score on both its financial health and profitability. ICUI has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
ICUI had positive earnings in the past year.
In the past year ICUI had a positive cash flow from operations.
In multiple years ICUI reported negative net income over the last 5 years.
Of the past 5 years ICUI 4 years had a positive operating cash flow.
1.2 Ratios
ICUI has a better Return On Assets (-0.18%) than 72.73% of its industry peers.
With a decent Return On Equity value of -0.35%, ICUI is doing good in the industry, outperforming 73.26% of the companies in the same industry.
ICUI has a Return On Invested Capital of 2.86%. This is in the better half of the industry: ICUI outperforms 70.59% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ICUI is significantly below the industry average of 8.81%.
The last Return On Invested Capital (2.86%) for ICUI is above the 3 year average (1.36%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.18% | ||
| ROE | -0.35% | ||
| ROIC | 2.86% |
ROA(3y)-1.71%
ROA(5y)1.06%
ROE(3y)-3.65%
ROE(5y)0.24%
ROIC(3y)1.36%
ROIC(5y)3.41%
1.3 Margins
ICUI has a Operating Margin of 5.63%. This is in the better half of the industry: ICUI outperforms 71.12% of its industry peers.
In the last couple of years the Operating Margin of ICUI has declined.
ICUI's Gross Margin of 36.47% is on the low side compared to the rest of the industry. ICUI is outperformed by 71.12% of its industry peers.
In the last couple of years the Gross Margin of ICUI has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.63% | ||
| PM (TTM) | N/A | ||
| GM | 36.47% |
OM growth 3Y-26.21%
OM growth 5Y-22.36%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.48%
GM growth 5Y-1.46%
2. Health
2.1 Basic Checks
ICUI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for ICUI has been increased compared to 1 year ago.
Compared to 5 years ago, ICUI has more shares outstanding
Compared to 1 year ago, ICUI has a worse debt to assets ratio.
2.2 Solvency
ICUI has an Altman-Z score of 2.19. This is not the best score and indicates that ICUI is in the grey zone with still only limited risk for bankruptcy at the moment.
ICUI has a Altman-Z score of 2.19. This is in the better half of the industry: ICUI outperforms 63.10% of its industry peers.
The Debt to FCF ratio of ICUI is 21.21, which is on the high side as it means it would take ICUI, 21.21 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 21.21, ICUI is doing good in the industry, outperforming 70.05% of the companies in the same industry.
ICUI has a Debt/Equity ratio of 0.62. This is a neutral value indicating ICUI is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.62, ICUI is doing worse than 62.03% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.62 | ||
| Debt/FCF | 21.21 | ||
| Altman-Z | 2.19 |
ROIC/WACC0.38
WACC7.62%
2.3 Liquidity
ICUI has a Current Ratio of 2.45. This indicates that ICUI is financially healthy and has no problem in meeting its short term obligations.
ICUI has a Current ratio of 2.45. This is comparable to the rest of the industry: ICUI outperforms 49.20% of its industry peers.
A Quick Ratio of 1.19 indicates that ICUI should not have too much problems paying its short term obligations.
ICUI has a Quick ratio of 1.19. This is in the lower half of the industry: ICUI underperforms 68.98% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.45 | ||
| Quick Ratio | 1.19 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 40.14% over the past year.
Measured over the past years, ICUI shows a decrease in Earnings Per Share. The EPS has been decreasing by -5.28% on average per year.
Looking at the last year, ICUI shows a decrease in Revenue. The Revenue has decreased by -0.84% in the last year.
Measured over the past years, ICUI shows a quite strong growth in Revenue. The Revenue has been growing by 13.47% on average per year.
EPS 1Y (TTM)40.14%
EPS 3Y-5.58%
EPS 5Y-5.28%
EPS Q2Q%27.67%
Revenue 1Y (TTM)-0.84%
Revenue growth 3Y21.86%
Revenue growth 5Y13.47%
Sales Q2Q%-8.85%
3.2 Future
The Earnings Per Share is expected to grow by 14.56% on average over the next years. This is quite good.
ICUI is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.95% yearly.
EPS Next Y23.92%
EPS Next 2Y14.84%
EPS Next 3Y14.98%
EPS Next 5Y14.56%
Revenue Next Year-4.6%
Revenue Next 2Y-3.09%
Revenue Next 3Y-0.65%
Revenue Next 5Y2.95%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 18.54, the valuation of ICUI can be described as rather expensive.
ICUI's Price/Earnings ratio is rather cheap when compared to the industry. ICUI is cheaper than 82.89% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.29. ICUI is valued slightly cheaper when compared to this.
With a Price/Forward Earnings ratio of 17.99, ICUI is valued on the expensive side.
83.42% of the companies in the same industry are more expensive than ICUI, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of ICUI to the average of the S&P500 Index (23.51), we can say ICUI is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.54 | ||
| Fwd PE | 17.99 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, ICUI is valued cheaper than 83.96% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ICUI indicates a somewhat cheap valuation: ICUI is cheaper than 73.26% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 58.55 | ||
| EV/EBITDA | 13.6 |
4.3 Compensation for Growth
ICUI's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ICUI's earnings are expected to grow with 14.98% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.78
PEG (5Y)N/A
EPS Next 2Y14.84%
EPS Next 3Y14.98%
5. Dividend
5.1 Amount
No dividends for ICUI!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
147.59
+5.11 (+3.59%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners117.94%
Inst Owner Change3.93%
Ins Owners0.96%
Ins Owner Change-1.93%
Market Cap3.64B
Revenue(TTM)2.32B
Net Income(TTM)-7.36M
Analysts83.33
Price Target185.03 (25.37%)
Short Float %5.5%
Short Ratio4.93
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)38.05%
Min EPS beat(2)37.25%
Max EPS beat(2)38.85%
EPS beat(4)4
Avg EPS beat(4)36.86%
Min EPS beat(4)31.74%
Max EPS beat(4)39.58%
EPS beat(8)8
Avg EPS beat(8)33.65%
EPS beat(12)12
Avg EPS beat(12)26.3%
EPS beat(16)15
Avg EPS beat(16)20.15%
Revenue beat(2)1
Avg Revenue beat(2)0.69%
Min Revenue beat(2)-1.77%
Max Revenue beat(2)3.14%
Revenue beat(4)3
Avg Revenue beat(4)1.65%
Min Revenue beat(4)-1.77%
Max Revenue beat(4)3.14%
Revenue beat(8)6
Avg Revenue beat(8)1.04%
Revenue beat(12)6
Avg Revenue beat(12)-0.86%
Revenue beat(16)8
Avg Revenue beat(16)-0.49%
PT rev (1m)4.13%
PT rev (3m)2.95%
EPS NQ rev (1m)-0.69%
EPS NQ rev (3m)-0.97%
EPS NY rev (1m)8.13%
EPS NY rev (3m)8.13%
Revenue NQ rev (1m)0.65%
Revenue NQ rev (3m)0.27%
Revenue NY rev (1m)0.98%
Revenue NY rev (3m)0.98%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.54 | ||
| Fwd PE | 17.99 | ||
| P/S | 1.57 | ||
| P/FCF | 58.55 | ||
| P/OCF | 22.85 | ||
| P/B | 1.71 | ||
| P/tB | N/A | ||
| EV/EBITDA | 13.6 |
EPS(TTM)7.96
EY5.39%
EPS(NY)8.2
Fwd EY5.56%
FCF(TTM)2.52
FCFY1.71%
OCF(TTM)6.46
OCFY4.38%
SpS93.98
BVpS86.16
TBVpS-1.47
PEG (NY)0.78
PEG (5Y)N/A
Graham Number124.22
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.18% | ||
| ROE | -0.35% | ||
| ROCE | 3.62% | ||
| ROIC | 2.86% | ||
| ROICexc | 3.12% | ||
| ROICexgc | 9.01% | ||
| OM | 5.63% | ||
| PM (TTM) | N/A | ||
| GM | 36.47% | ||
| FCFM | 2.68% |
ROA(3y)-1.71%
ROA(5y)1.06%
ROE(3y)-3.65%
ROE(5y)0.24%
ROIC(3y)1.36%
ROIC(5y)3.41%
ROICexc(3y)1.47%
ROICexc(5y)4.61%
ROICexgc(3y)4.17%
ROICexgc(5y)7.18%
ROCE(3y)1.72%
ROCE(5y)4.32%
ROICexgc growth 3Y-18.09%
ROICexgc growth 5Y-16.18%
ROICexc growth 3Y-37.66%
ROICexc growth 5Y-28.8%
OM growth 3Y-26.21%
OM growth 5Y-22.36%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.48%
GM growth 5Y-1.46%
F-Score7
Asset Turnover0.57
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.62 | ||
| Debt/FCF | 21.21 | ||
| Debt/EBITDA | 3.95 | ||
| Cap/Depr | 47.91% | ||
| Cap/Sales | 4.19% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 47.79% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.45 | ||
| Quick Ratio | 1.19 | ||
| Altman-Z | 2.19 |
F-Score7
WACC7.62%
ROIC/WACC0.38
Cap/Depr(3y)41.42%
Cap/Depr(5y)66.41%
Cap/Sales(3y)4.1%
Cap/Sales(5y)5.27%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)40.14%
EPS 3Y-5.58%
EPS 5Y-5.28%
EPS Q2Q%27.67%
EPS Next Y23.92%
EPS Next 2Y14.84%
EPS Next 3Y14.98%
EPS Next 5Y14.56%
Revenue 1Y (TTM)-0.84%
Revenue growth 3Y21.86%
Revenue growth 5Y13.47%
Sales Q2Q%-8.85%
Revenue Next Year-4.6%
Revenue Next 2Y-3.09%
Revenue Next 3Y-0.65%
Revenue Next 5Y2.95%
EBIT growth 1Y142.55%
EBIT growth 3Y-10.08%
EBIT growth 5Y-11.9%
EBIT Next Year43.36%
EBIT Next 3Y18.75%
EBIT Next 5Y17.88%
FCF growth 1Y597.89%
FCF growth 3Y-15.14%
FCF growth 5YN/A
OCF growth 1Y117.81%
OCF growth 3Y-8.63%
OCF growth 5Y14.9%
ICU MEDICAL INC / ICUI FAQ
What is the ChartMill fundamental rating of ICU MEDICAL INC (ICUI) stock?
ChartMill assigns a fundamental rating of 4 / 10 to ICUI.
What is the valuation status of ICU MEDICAL INC (ICUI) stock?
ChartMill assigns a valuation rating of 6 / 10 to ICU MEDICAL INC (ICUI). This can be considered as Fairly Valued.
How profitable is ICU MEDICAL INC (ICUI) stock?
ICU MEDICAL INC (ICUI) has a profitability rating of 4 / 10.
What is the expected EPS growth for ICU MEDICAL INC (ICUI) stock?
The Earnings per Share (EPS) of ICU MEDICAL INC (ICUI) is expected to grow by 23.92% in the next year.